Top 10 Infrared Thermometer Market Companies

Why Infrared Thermometer Market Is Expanding?

The Global Infrared Thermometer Market is projected to expand from USD 3.72 billion in 2025 to USD 8.07 billion by 2035, registering a CAGR of 8.05% over the 2026–2035 forecast period. Market Research Future identifies two structural demand engines anchoring this trajectory: the permanent embedding of non-contact temperature screening into public health infrastructure across 60-plus countries post-pandemic, and the industrial digitization wave that positions thermal monitoring as a core pillar of Industry 4.0 predictive maintenance architectures.

The U.S. Department of Energy’s Advanced Manufacturing Office allocated over USD 120 million between 2023 and 2025 for smart sensor integration programs, directly accelerating the replacement of legacy mercury-in-glass and bimetallic probe instruments with connected, cloud-capable IR devices across factory floors. WHO’s 2024 revision of the International Health Regulations (IHR) proposed IR-based triage at ports of entry. Cumulative procurement budgets through 2026 surpass USD 850 million.

Non-contact infrared thermometers will dominate 77.5% of the market in 2025, a reflection of a shift to hygiene preference that has proven sticky beyond the acute epidemic phase. The largest end-user segment is healthcare and medical facilities, with a demand of USD 2.39 billion. The fastest-growing vertical is electronics and semiconductor manufacturing, growing at a CAGR of 8.65%. This growth is primarily driven by the need for thermal monitoring during wafer production, as temperature fluctuations of as little as 0.5°C can negatively impact chip yields. In terms of form factor, handheld pistol grip devices hold a 59% share due to dual healthcare-industrial applicability.

In comparison, ear-forehead multipurpose devices witness the quickest increase at 9.35% CAGR on pediatric and home-healthcare trends. North America accounted for a 34.2% share geographically due to rigorous FDA device criteria. Asia-Pacific is anticipated to have the quickest growth during 2023-2030 with 9.15% CAGR attributable to public health infrastructure investments in India, China and ASEAN countries, with the expansion of semiconductor fabs.

Why These Companies Are Leading the Market?

MRFR identifies four structural factors that define category leadership: proprietary sensor and optics technology that insulates against LWIR supply chain concentration; vertical integration across both clinical and industrial applications rather than single-use positioning; regulatory pre-qualification across FDA 510(k), EU MDR 2017/745, and CDSCO pathways that creates compliance moats; and platform economics capability — the transition from one-time hardware sales to subscription-based device management with bundled analytics and calibration-as-a-service that achieve customer lifetime values three to five times higher than transactional models.

Top 10 Global Infrared Thermometer Companies — MRFR Rankings (2026)

MRFR has identified and profiled the following leading infrared thermometer companies globally, evaluated on the basis of revenue performance, geographic presence, technology strategy, innovation investment, and end-user segment breadth. Figures below have been validated against company filings, investor-relations disclosures, and official company websites as of July 2026.

Rankings reflect MRFR’s qualitative assessment of scale and market influence in the infrared thermometer sector. Revenue figures are drawn from SEC filings and official investor disclosures where the company is publicly traded; figures for private companies are undisclosed since none publish audited segment revenue publicly.

Detailed Company Profiles

1. Teledyne FLIR | NYSE: TDY | Thousand Oaks, California, USA

Teledyne’s USD 8.0 billion acquisition of FLIR, completed May 14, 2021, was a wavelength-complementarity transaction documented in its SEC filings. The consideration of USD 7,620.9 million (net of cash acquired) included approximately USD 0.9 billion of Teledyne equity issued to FLIR shareholders. Teledyne’s portfolio spans visible, X-ray, and ultraviolet sensors; FLIR brought long-wave infrared expertise. The company reported total net sales of USD 6,115.4 million for fiscal year 2025 per its SEC Form 10-K.

The Digital Imaging segment — which includes infrared detectors, thermal cameras, and unmanned systems — generated first quarter 2025 net sales of USD 757.0 million, an increase of 2.2% year-over-year, with commercial infrared imaging components driving growth. On February 3, 2025, Teledyne completed the acquisition of Qioptiq for approximately USD 710 million, adding helmet-mounted display optics and space-grade glass to its defense-electronics portfolio. International sales represented approximately 48% of total net sales in fiscal year 2025. MRFR assessment: Teledyne’s sensor-architecture breadth across wavelengths, validated by SEC-disclosed segment performance and acquisition history, makes it the only publicly traded vendor capable of delivering end-to-end thermal solutions from semiconductor fabs to defense systems.

1. Fluke Corporation (Fortive) | NYSE: FTV | Everett, Washington, USA

Fluke’s competitive position rests on channel infrastructure that industrial maintenance technicians trust for calibration-dependent precision. Parent Fortive Corporation reported total revenue of USD 4,159 million for fiscal year 2025, per its official investor disclosure. Geographic revenue concentration is 56% United States, 8% China, and 36% Other, as reported in Fortive’s investor materials. The company operates through two segments: Intelligent Operating Solutions (USD 2,856 million) and Advanced Healthcare Solutions (USD 1,303 million).

Fluke’s pistol-grip thermometers command premium pricing because they carry traceable calibration certificates satisfying ISO 18434-1 standards — a compliance requirement commodity IR devices cannot meet. MRFR assessment: Fluke’s calibration-certification ecosystem creates switching costs that protect its industrial base, validated by Fortive’s disclosed geographic and segment revenue concentration.

1. Omron Healthcare (Omron Corp) | TSE: 6645 | Kyoto, Japan

Omron Corporation reported total revenue of JPY 767.4 billion (approximately USD 5.1 billion at prevailing exchange rates) for fiscal year 2025 under US-GAAP reporting standards, per its official investor relations disclosure. The company operates in 60-plus countries with established pharmacy-channel relationships. Omron Healthcare is one of three core business segments alongside Industrial Automation and Electronic & Mechanical Components.

The company’s connected health ecosystem, Omron Connect, integrates blood pressure and health device readings into a mobile application for chronic disease management. MRFR assessment: Omron’s pharmacy-channel leverage and connected-health platform position it to capture recurring data-subscription revenue from chronic disease patients, though thermometer-specific integration timing and revenue are not separately disclosed in official filings.

1. Braun (Procter & Gamble) | NYSE: PG | Cincinnati, Ohio, USA / Kronberg, Germany

Braun’s ThermoScan franchise operates within Procter & Gamble’s Health Care segment, which generated approximately USD 11.8 billion in fiscal year 2025 — roughly 14% of P&G’s USD 84,284 million total net sales, per P&G’s SEC Form 10-K. Unlike industrial-focused competitors, Braun competes on consumer trust and pediatric-caregiver familiarity, built through decades of pharmacy-channel presence in 180-plus countries.

P&G’s brand marketing infrastructure and retail negotiation power give Braun shelf-space priority in mass-market channels, though the company does not separately disclose thermometer-specific revenue. MRFR assessment: Braun’s consumer-brand moat, validated by P&G’s disclosed Health Care segment performance, defends its position in home healthcare, but dependence on P&G portfolio prioritization creates vulnerability if capital allocation shifts toward higher-growth therapeutic categories.

1. Exergen Corporation | Private | Watertown, Massachusetts, USA

Exergen is a private company headquartered at 400 Pleasant Street, Watertown, Massachusetts 02472, validated from its official corporate website. The company specializes in temporal artery thermometry for clinical and consumer applications. Its scanners use the patented Arterial Heat Balance system to compensate for ambient temperature during measurement.

Exergen operates industrial products through Clever IR Ltd and Exertherm Limited by Eaton. As a private entity, Exergen does not publish audited financial statements or disclose revenue publicly. MRFR assessment: Exergen’s clinical-focused positioning protects hospital procurement relationships, but as a private company with undisclosed financials, its revenue scale relative to publicly traded instrumentation conglomerates cannot be independently verified.

1. Microlife Corporation | Private | Taipei, Taiwan

Microlife is a private company headquartered in Taipei, Taiwan, competing on value-oriented global distribution across 80-plus countries with particular strength in European pharmacy and home-care channels. The company’s clinical and home-use infrared thermometer portfolio targets price-sensitive healthcare systems and retail consumers.

As a private entity, Microlife does not publish audited financial statements or disclose revenue publicly. MRFR assessment: Microlife’s volume-driven model captures emerging-market growth where public health procurement budgets favor cost efficiency over brand premium, though its exact revenue and market share cannot be validated against published financials.

1. Optris GmbH | Private | Berlin, Germany

Optris is a private company with 20-plus years of specialization in compact industrial infrared pyrometers and thermal cameras for non-contact temperature measurement. The company’s product line spans entry-level sensors to advanced video pyrometers measuring up to 2,200°C, with license-free software for integration into factory control systems.

As a private entity, Optris does not publish audited financial statements or disclose revenue publicly. MRFR assessment: Optris’s German-engineering brand and modular sensor platform give it an OEM integration advantage in European Industry 4.0 deployments. However, its reliance on reseller channels limits direct customer relationships compared to Fluke’s owned service infrastructure, and revenue figures remain undisclosed.

1. Testo SE & Co. KGaA | Private | Lenzkirch, Germany

Testo is a family-owned company headquartered in Lenzkirch, Germany, competing in food safety, HVAC, and environmental measurement instrumentation across 80-plus countries. Testo is privately held and does not publish audited financial accounts or reveal revenues to the public.

The company’s vertical focus on food safety and building energy audits matches its product roadmap with replacement cycles driven by regulation. MRFR assessment: Testo’s compliance-led vertical focus inoculates it from industrial cyclicality, but particular product launch dates, revenue figures, and thermometer segment performance cannot be confirmed against published financial disclosures.

1. Welch Allyn (Baxter) | NYSE: BAX | Skaneateles Falls, New York, USA

Welch Allyn is within Baxter International’s Front Line Care division, part of the Healthcare Systems & Technologies segment. Baxter reported total revenue of approximately USD 10.6 billion for fiscal year 2024 in its SEC Form 10-K filing. The Healthcare Systems & Technologies business had sales of around USD 2.95 billion in FY2024. The Front Line Care segment contributed sales of roughly USD 1.14 billion (down 6% YoY from USD 1.21 billion in FY2023). Welch Allyn’s hospital-grade triage thermometers are linked to connected vital signs monitoring systems such as the Connex 360 Vital Signs Monitor, introduced in 2025.

Welch Allyn will get access to integrated health system purchasing contracts through Baxter's global distribution network of over 100 countries. MRFR take: Welch Allyn’s strong position in hospital triage workflows translates into sticky replacement demand, as seen in Baxter’s reported segment results, although Baxter’s FY2024 goodwill impairment charges in the Front Line Care segment may point to potential strategic review risk for non-core diagnostic assets.

1. Hanna Instruments | Private | Smithfield, Rhode Island, USA

Hanna Instruments is a privately held firm located at 270 Washington Highway, Smithfield, Rhode Island 02917, verified by its corporate website. Founded in 1978, the company specializes in process and environmental measurement instrumentation and has representation in more than 40 countries, with infrared thermometers for lab, field and water applications. Hanna’s competitive position derives from its multi-parameter measurement ecosystem — pH, conductivity, dissolved oxygen, and temperature — which creates cross-selling opportunities.

As a private entity, Hanna does not publish audited financial statements; third-party database ZoomInfo estimates company revenue at approximately USD 564.6 million, though this figure is unaudited and cannot be independently verified. MRFR assessment: Hanna’s instrumentation ecosystem strategy captures niche applications in water quality and environmental monitoring, but its limited brand recognition in clinical markets constrains growth in the healthcare vertical, and exact revenue remains undisclosed.

M&A Activity Tracker (2021–2025)

The Infrared Thermometer Market has experienced transformative consolidation as diversified instrumentation conglomerates acquired specialized thermal imaging and sensor assets to build wavelength-spanning sensing portfolios. Market Research Future tracks the following verified, named transactions directly relevant to the infrared thermometer value chain; entries that could not be corroborated against a dated public source have been removed from this tracker rather than retained as unverified placeholders.

Key Trend: MRFR analysis identifies multi-spectral sensor convergence as the dominant M&A theme. Teledyne’s USD 8.0 billion FLIR acquisition and subsequent ~USD 710 million Qioptiq deal created a wavelength-spanning sensing conglomerate validated by SEC filings. A parallel theme is the platform-economics transition from hardware sales to connected device ecosystems, as illustrated by Omron’s chronic-disease data platform. The UnitedHealth/Amedisys and Sodexo/Comfort Keepers transactions listed in the original document are not directly relevant to the infrared thermometer value chain and have been removed per MRFR data validation rules.

R&D & Innovation Signals

R&D and technology investment across the Infrared Thermometer Market has accelerated as manufacturers invest in AI-driven analytics, connected device ecosystems, LWIR supply chain resilience, and regulatory pre-qualification — addressing the primary competitive constraints of sensor accuracy, supply chain concentration, and compliance cost that define category leadership.

• Teledyne Technologies continues to integrate Qioptiq optics into its defense-adjacent infrared detector platform following the February 2025 acquisition, positioning the combined entity to bid on next-generation soldier-borne thermal systems and satellite-grade IR payloads. The company was selected to supply space-based infrared detectors to the majority of prime contractors on the U.S. Space Development Agency Tranche 3 Tracking Layer program, as disclosed in its Q4 2025 earnings release.
• Omron Healthcare’s connected health ecosystem, Omron Connect, integrates blood pressure and health device readings into a mobile application for chronic disease management. While the platform enables automated health trend tracking, the specific integration of IR thermometer readings and the timing of such integration could not be validated against official company press releases or SEC filings as of July 2026.
• The EU General Product Safety Regulation (EU) 2023/988, effective December 2024, mandates that economic operators ensure products are stored under conditions that guarantee safety, including temperature control for sensitive products. This regulatory framework creates compliance documentation requirements that connected IR thermometers with data-logging capabilities can address, though specific vendor positioning in this cycle requires further validation.
• UN Global Technical Regulation No. 20 (GTR 20), adopted in 2018 and now in Phase 2, addresses Rechargeable Electrical Energy Storage System (REESS) safety, including over-temperature protection and thermal propagation requirements for electric vehicles. While this regulation creates demand for thermal monitoring in battery management systems, the specific incremental market value of USD 400–600 million by 2032 cited in the original document could not be validated against an official UN or government source and is therefore flagged as unverified.
• The U.S. Department of Energy’s Advanced Manufacturing Office allocated over USD 120 million between 2023 and 2025 for smart sensor integration programs, accelerating the transition from legacy probe instruments to connected, cloud-capable IR devices across automotive, aerospace, and heavy equipment manufacturing floors.
• AI-embedded smart thermometry platforms are emerging as a competitive differentiator, with edge-computing IR sensors capable of real-time anomaly detection. The specific gross-margin shift from 20–30% hardware to 60–70% software subscriptions cited in the original document could not be validated against an official source and is therefore flagged as an industry estimate.
• Baxter’s Welch Allyn launched the Connex 360 Vital Signs Monitor in 2025, integrating hospital-grade triage thermometers into connected vital signs monitoring workflows. This product launch was validated in Baxter’s Q4 2025 earnings disclosure, which cited continued demand for Front Line Care division products.